Month: November 2020
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Infographic – Public Favors Rejoining Paris Accord
A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agreement.
-
Trial Requested for Covid-19 Vaccine Nasal Spray
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine.
-
Wheat Genome Study IDs Critical Genes, Traits
An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival.
-
Building Credibility as a Budding Developer
As businesses continue to evolve, it is clear that credibility is becoming a reliable component to retain your customer base.
-
Trial Underway Testing Insulin Capsules
Researchers began screening participants for a clinical trial assessing insulin formulated as capsules for people with type 2 diabetes.
-
Therapist-Guided Home Stroke Rehab System in Works
A university lab is designing a system that allows for people with stroke to perform rehabilitation at home, while still guided remotely by a therapist.
-
Lightweight AI Chip Designer Raises $2.8M in Seed Funds
A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems.
-
Trial Testing Magnetic Waves for Bipolar Depression
Researchers are enrolling patients in a clinical trial testing magnetic waves to induce small seizures as a treatment for depression from bipolar disorder.
-
Natural-Killer Cell Cancer Therapy Biotech Launches
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds.